Filing Details
- Accession Number:
- 0000886163-17-000081
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-23 16:16:40
- Reporting Period:
- 2008-02-23
- Filing Date:
- 2017-06-23
- Accepted Time:
- 2017-06-23 16:16:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208906 | L John Higgins | 3911 Sorrento Valley Boulevard, Ste 110 San Diego CA 92121 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-21 | 4,666 | $21.00 | 143,837 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-21 | 4,666 | $120.00 | 139,171 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2008-02-23 | 4,666 | $0.00 | 4,666 | $21.00 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-06-21 | 4,666 | $0.00 | 4,666 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,666 | 2009-02-15 | 2018-02-23 | No | 4 | A | Direct |
| 0 | 2009-02-15 | 2018-02-23 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 11, 2017, in accordance with Rule 10b5-1.
- On February 23, 2008, the Reporting Person was granted an option to purchase 4,666 shares of common stock. The option vested in full on February 15, 2009 based on the satisfaction of certain performance goals.
Billionaire Hedge Funds
